CZ279793A3 - Orally active antiviral compounds - Google Patents

Orally active antiviral compounds Download PDF

Info

Publication number
CZ279793A3
CZ279793A3 CS932797A CS279793A CZ279793A3 CZ 279793 A3 CZ279793 A3 CZ 279793A3 CS 932797 A CS932797 A CS 932797A CS 279793 A CS279793 A CS 279793A CZ 279793 A3 CZ279793 A3 CZ 279793A3
Authority
CZ
Czechia
Prior art keywords
compound
alkyl
formula
compounds
compound according
Prior art date
Application number
CS932797A
Other languages
Czech (cs)
English (en)
Inventor
Viyyoor M Girijavallabhan
Ashit K Ganguly
Richard W Versace
Anil K Saksena
Patrick A Pinto
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CZ279793A3 publication Critical patent/CZ279793A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/28—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
CS932797A 1991-06-19 1992-06-17 Orally active antiviral compounds CZ279793A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71745191A 1991-06-19 1991-06-19
PCT/US1992/004961 WO1992022520A1 (en) 1991-06-19 1992-06-17 Orally active antiviral compounds

Publications (1)

Publication Number Publication Date
CZ279793A3 true CZ279793A3 (en) 1994-05-18

Family

ID=24882086

Family Applications (1)

Application Number Title Priority Date Filing Date
CS932797A CZ279793A3 (en) 1991-06-19 1992-06-17 Orally active antiviral compounds

Country Status (23)

Country Link
US (4) US5559133A (enExample)
EP (2) EP0519702A1 (enExample)
JP (1) JP2625258B2 (enExample)
KR (1) KR960004887B1 (enExample)
AT (1) ATE182874T1 (enExample)
AU (1) AU674657B2 (enExample)
CA (1) CA2111854C (enExample)
CZ (1) CZ279793A3 (enExample)
DE (1) DE69229733T2 (enExample)
ES (1) ES2134808T3 (enExample)
FI (1) FI935690A0 (enExample)
IE (1) IE921971A1 (enExample)
IL (1) IL102241A0 (enExample)
MX (1) MX9203068A (enExample)
MY (1) MY107993A (enExample)
NZ (1) NZ243180A (enExample)
OA (1) OA09828A (enExample)
PL (1) PL169699B1 (enExample)
SK (1) SK144293A3 (enExample)
TW (1) TW260658B (enExample)
WO (1) WO1992022520A1 (enExample)
YU (1) YU63392A (enExample)
ZA (1) ZA924445B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519702A1 (en) * 1991-06-19 1992-12-23 Schering Corporation Orally active antiviral compounds
AU691490B2 (en) * 1993-02-26 1998-05-21 Schering Corporation Use of 2-chloro-1-{{4-{(2,6-dichlorophenoxy)methyl}-phenyl}methoxy} -4-methoxy-benzene for the selective treatment of enteroviral infections in humans
AU6783698A (en) * 1997-04-10 1998-10-30 Pharmacia & Upjohn Company Polyaromatic antiviral compositions
AU6462500A (en) * 1999-07-29 2001-02-19 Patrick T. Prendergast Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2418571A1 (de) * 1973-04-18 1974-11-14 Ciba Geigy Ag Phenyl-aralkyl-aether, diphenyle und benzophenone, verfahren zu ihrer herstellung und ihre verwendung
JPS509785A (enExample) * 1973-05-31 1975-01-31
JPS5922697B2 (ja) * 1976-01-13 1984-05-28 エーザイ株式会社 ビス−（メタ−アミジノフエノキシ）−化合物
JPS5651423A (en) * 1979-09-13 1981-05-09 Wellcome Found Antiviral agent
EP0099933B1 (en) * 1982-01-29 1986-04-02 Toray Industries, Inc. Process for preparing alpha,omega-bis(2-chlorophenoxy)-alkane-4,4'-dicarboxylic acid or its lower alkyl ester
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
JPH0621083B2 (ja) * 1986-12-22 1994-03-23 株式会社三光開発科学研究所 ジ（アリ−ルオキシ）アルカンの製造方法
US4891449A (en) * 1988-06-30 1990-01-02 Great Lakes Chemical Corporation Halogenated unsymmetrical higher alkyl phenoxy alkanes
AU6062590A (en) * 1989-07-07 1991-02-06 Schering Corporation Pharmaceutically active compounds
EP0519702A1 (en) * 1991-06-19 1992-12-23 Schering Corporation Orally active antiviral compounds

Also Published As

Publication number Publication date
CA2111854C (en) 2001-01-09
DE69229733D1 (de) 1999-09-09
US5350772A (en) 1994-09-27
TW260658B (enExample) 1995-10-21
PL169699B1 (en) 1996-08-30
EP0519702A1 (en) 1992-12-23
YU63392A (sh) 1994-11-15
ATE182874T1 (de) 1999-08-15
OA09828A (en) 1994-04-15
WO1992022520A1 (en) 1992-12-23
US5618849A (en) 1997-04-08
ZA924445B (en) 1993-02-24
EP0590026B1 (en) 1999-08-04
US5449782A (en) 1995-09-12
FI935690A7 (fi) 1993-12-17
AU2221392A (en) 1993-01-12
DE69229733T2 (de) 1999-12-02
JPH06503839A (ja) 1994-04-28
FI935690A0 (fi) 1993-12-17
JP2625258B2 (ja) 1997-07-02
AU674657B2 (en) 1997-01-09
KR960004887B1 (ko) 1996-04-16
MY107993A (en) 1996-07-15
EP0590026A1 (en) 1994-04-06
NZ243180A (en) 1995-08-28
CA2111854A1 (en) 1992-12-23
US5559133A (en) 1996-09-24
IL102241A0 (en) 1993-01-14
MX9203068A (es) 1993-07-01
ES2134808T3 (es) 1999-10-16
IE921971A1 (en) 1992-12-30
SK144293A3 (en) 1994-06-08

Similar Documents

Publication Publication Date Title
KR102477187B1 (ko) 피리돈 유도체, 이의 입체 이성질체 및 항인플루엔자 바이러스 약물로서의 응용
AU2011281134B2 (en) Agonists of GPR40
CA2065644C (en) Pyrazolopyridine compound and processes for preparation thereof
WO2019226991A1 (en) Androgen receptor modulators and methods for their use
HUT64514A (en) Process for producing arylic comdounds with anti-atherosclerotic effect
CN112047944A (zh) 一种选择性抑制激酶化合物及其用途
CA2085687A1 (en) New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
JP7636831B2 (ja) 新規なビフェニル誘導体及びその調製方法並びに医薬用途
CZ279793A3 (en) Orally active antiviral compounds
JP2022542613A (ja) ヒトａｔｇｌの阻害剤
CN106966986B (zh) N-苄基硝基杂环烯酮缩胺类衍生物及合成方法和抗肿瘤应用
TW202421155A (zh) 葫蘆脲類化合物及其醫藥用途
JP7716980B2 (ja) エストロゲン受容体拮抗剤
CN111393421A (zh) 丁烯酸内酯类衍生物及其制备方法与应用
TWI828783B (zh) 聯芳基衍生物及其用途
SE442110B (sv) 4-pikolyltioettiksyror och alkylestrar derav till anvendning for reglering av immunforsvaret hos deggdjur
SI9400221A (en) Orally active antipicornaviral compounds
WO2025090901A1 (en) Ros-activated co prodrugs for cancer treatment
JPS6130645B2 (enExample)
HRP920365A2 (en) Bis(oxy) compounds and process for their preparation
IT8247629A1 (it) Derivati del silicio, loro preparazione e loro applicazione come medicamenti
NZ270131A (en) Orally active antiviral aromatic ether compounds
HK40110761A (en) Therapeutic uses of deuterated derivatives of lanifibranor
JPH0253786A (ja) 肝臓疾患治療剤